These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38643415)

  • 1. Confounding factors of the expression of mTBI biomarkers, S100B, GFAP and UCH-L1 in an aging population.
    Calluy E; Beaudart C; Alokail MS; Al-Daghri NM; Bruyère O; Reginster JY; Cavalier E; Ladang A
    Clin Chem Lab Med; 2024 Sep; 62(10):2062-2069. PubMed ID: 38643415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial Fibrillary Acidic Protein (GFAP) Outperforms S100 Calcium-Binding Protein B (S100B) and Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) as Predictor for Positive Computed Tomography of the Head in Trauma Subjects.
    Mahan MY; Thorpe M; Ahmadi A; Abdallah T; Casey H; Sturtevant D; Judge-Yoakam S; Hoover C; Rafter D; Miner J; Richardson C; Samadani U
    World Neurosurg; 2019 Aug; 128():e434-e444. PubMed ID: 31051301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury.
    Lewis LM; Schloemann DT; Papa L; Fucetola RP; Bazarian J; Lindburg M; Welch RD
    Acad Emerg Med; 2017 Jun; 24(6):710-720. PubMed ID: 28170122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury.
    Welch RD; Ayaz SI; Lewis LM; Unden J; Chen JY; Mika VH; Saville B; Tyndall JA; Nash M; Buki A; Barzo P; Hack D; Tortella FC; Schmid K; Hayes RL; Vossough A; Sweriduk ST; Bazarian JJ
    J Neurotrauma; 2016 Jan; 33(2):203-14. PubMed ID: 26467555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury.
    Welch RD; Ellis M; Lewis LM; Ayaz SI; Mika VH; Millis S; Papa L
    J Neurotrauma; 2017 Jun; 34(11):1957-1971. PubMed ID: 28031000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Using a Rapid Point of Care Test for Predicting Head Computed Tomography Lesions After Mild Traumatic Brain Injury in a Dutch Multi-Center Cohort.
    Chayoua W; Visser K; de Koning ME; Beishuizen A; IJmker R; van der Naalt J; Krabbe JG; van der Horn HJ
    J Neurotrauma; 2024 Jul; 41(13-14):e1630-e1640. PubMed ID: 38326742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of GFAP and UCH-L1 Measurements Using Two Automated Immunoassays (i-STAT
    Oris C; Khatib-Chahidi C; Pereira B; Bailly Defrance V; Bouvier D; Sapin V
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minor head injury in anticoagulated patients: performance of biomarkers S100B, NSE, GFAP, UCH-L1 and Alinity TBI in the detection of intracranial injury. A prospective observational study.
    Menditto VG; Moretti M; Babini L; Mattioli A; Giuliani AR; Fratini M; Pallua FY; Andreoli E; Nitti C; Contucci S; Gabrielli A; Rocchi MBL; Pomponio G
    Clin Chem Lab Med; 2024 Jun; 62(7):1376-1382. PubMed ID: 38206121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Assessment of Acute Blood Markers of Brain Injury in Sport-Related Concussion.
    Meier TB; Nelson LD; Huber DL; Bazarian JJ; Hayes RL; McCrea MA
    J Neurotrauma; 2017 Nov; 34(22):3134-3142. PubMed ID: 28699381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood Biomarkers for the Management of Mild Traumatic Brain Injury in Clinical Practice.
    Oris C; Kahouadji S; Bouvier D; Sapin V
    Clin Chem; 2024 Aug; 70(8):1023-1036. PubMed ID: 38656380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of Blood-Based Brain Biomarkers for Screening Adults with Mild Traumatic Brain Injury in the French Health Care Setting.
    Zimmer L; McDade C; Beyhaghi H; Purser M; Textoris J; Krause A; Blanc E; Pavlov V; Earnshaw S
    J Neurotrauma; 2023 Apr; 40(7-8):706-719. PubMed ID: 36267001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100B vs. "GFAP and UCH-L1" assays in the management of mTBI patients.
    Oris C; Bouillon-Minois JB; Kahouadji S; Pereira B; Dhaiby G; Defrance VB; Durif J; Schmidt J; Moustafa F; Bouvier D; Sapin V
    Clin Chem Lab Med; 2024 Apr; 62(5):891-899. PubMed ID: 38033294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploratory analysis of glial fibrillary acidic protein and ubiquitin C-terminal hydrolase L1 in management of patients with mild neurological symptoms undergoing head computed tomography scan at the emergency department: a pilot study from a Croatian tertiary hospital.
    Lapić I; Rogić D; Lončar Vrančić A; Gornik I
    Lab Med; 2024 Jul; 55(4):492-497. PubMed ID: 38363974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100B, GFAP, UCH-L1 and NSE as predictors of abnormalities on CT imaging following mild traumatic brain injury: a systematic review and meta-analysis of diagnostic test accuracy.
    Amoo M; Henry J; O'Halloran PJ; Brennan P; Husien MB; Campbell M; Caird J; Javadpour M; Curley GF
    Neurosurg Rev; 2022 Apr; 45(2):1171-1193. PubMed ID: 34709508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.
    Frankel M; Fan L; Yeatts SD; Jeromin A; Vos PE; Wagner AK; Wolf BJ; Pauls Q; Lunney M; Merck LH; Hall CL; Palesch YY; Silbergleit R; Wright DW
    J Neurotrauma; 2019 Oct; 36(20):2863-2871. PubMed ID: 30794101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Blood and Computed Tomographic Imaging Biomarkers in a Cohort of Mild Traumatic Brain Injury Patients.
    Chen H; Ding VY; Zhu G; Jiang B; Li Y; Boothroyd D; Rezaii PG; Bet AM; Paulino AD; Weber A; Glushakova OY; Hayes RL; Wintermark M
    J Neurotrauma; 2022 Oct; 39(19-20):1329-1338. PubMed ID: 35546284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury.
    Papa L; Brophy GM; Welch RD; Lewis LM; Braga CF; Tan CN; Ameli NJ; Lopez MA; Haeussler CA; Mendez Giordano DI; Silvestri S; Giordano P; Weber KD; Hill-Pryor C; Hack DC
    JAMA Neurol; 2016 May; 73(5):551-60. PubMed ID: 27018834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of ubiquitin carboxy-terminal hydrolase L1 elevations in athletes after sub-concussive head hits.
    Puvenna V; Brennan C; Shaw G; Yang C; Marchi N; Bazarian JJ; Merchant-Borna K; Janigro D
    PLoS One; 2014; 9(5):e96296. PubMed ID: 24806476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Performance of Traumatic Brain Injury Biomarkers in High-Risk Elderly Patients.
    Ward MD; Weber A; Merrill VD; Welch RD; Bazarian JJ; Christenson RH
    J Appl Lab Med; 2020 Jan; 5(1):91-100. PubMed ID: 32445344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interest of blood biomarkers to predict lesions in medical imaging in the context of mild traumatic brain injury.
    Bouvier D; Oris C; Brailova M; Durif J; Sapin V
    Clin Biochem; 2020 Nov; 85():5-11. PubMed ID: 32781055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.